Eli Lilly price objective raised to $1,397 from $1,341
LLY•BofA Global Research raised its price objective for Eli Lilly to $1,397 from $1,341.
Related News
Vornado Realty Trust: BMO cuts target price to $41 from $43
VNO•
Bioxytran completes production of two dietary supplements
BIXT•
Stifel cuts Lincoln Electric Holdings target price to $271 from $275
LECO•
Stifel cuts ESAB target price to $114 from $132
ESAB•
TCGX Acquisition agrees to combine with TriGemX Bio
TCGX•